BRPI0515727A - biomarcador para insuficiência cardìaca - Google Patents

biomarcador para insuficiência cardìaca

Info

Publication number
BRPI0515727A
BRPI0515727A BRPI0515727-7A BRPI0515727A BRPI0515727A BR PI0515727 A BRPI0515727 A BR PI0515727A BR PI0515727 A BRPI0515727 A BR PI0515727A BR PI0515727 A BRPI0515727 A BR PI0515727A
Authority
BR
Brazil
Prior art keywords
heart failure
biomarker
patients
bark1
lymphocytes
Prior art date
Application number
BRPI0515727-7A
Other languages
English (en)
Inventor
Walter J Koch
Guido Iaccarino
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of BRPI0515727A publication Critical patent/BRPI0515727A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"BIOMARCADOR PARA INSUFICIêNCIA CARDìADA". A presente invenção se refere genericamente a insuficiência cardíaca e, em particular, a um método de avaliação de pacientes com insuficiência cardíaca por monitorização dos níves de quinase de receptor B-adrenérgico (Bark1) em linfócitos desses pacientes.
BRPI0515727-7A 2004-11-08 2005-11-04 biomarcador para insuficiência cardìaca BRPI0515727A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62571904P 2004-11-08 2004-11-08
PCT/US2005/040231 WO2006052857A2 (en) 2004-11-08 2005-11-04 Biomarker for heart failure

Publications (1)

Publication Number Publication Date
BRPI0515727A true BRPI0515727A (pt) 2008-08-05

Family

ID=36337092

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515727-7A BRPI0515727A (pt) 2004-11-08 2005-11-04 biomarcador para insuficiência cardìaca

Country Status (13)

Country Link
US (1) US20090053696A1 (pt)
EP (1) EP1810027A4 (pt)
JP (1) JP2008519283A (pt)
KR (1) KR20070101241A (pt)
CN (1) CN101084439A (pt)
AU (1) AU2005304819A1 (pt)
BR (1) BRPI0515727A (pt)
CA (1) CA2586922A1 (pt)
IL (1) IL183036A0 (pt)
MX (1) MX2007005435A (pt)
NO (1) NO20072615L (pt)
WO (1) WO2006052857A2 (pt)
ZA (1) ZA200703666B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4778807B2 (ja) * 2006-02-17 2011-09-21 株式会社リコー 画像形成装置
EP2646572B1 (en) * 2010-12-01 2017-02-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Diagnostic and treatment of chronic heart failure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2228970A1 (en) * 1995-08-18 1997-02-27 Donald W. Landry Detection of organic compounds through regulation of antibody-catalyzed reactions
CA2551882A1 (en) * 2004-01-19 2005-08-11 Martek Biosciences Corporation Reelin deficiency or dysfunction and methods related thereto

Also Published As

Publication number Publication date
CN101084439A (zh) 2007-12-05
IL183036A0 (en) 2007-09-20
US20090053696A1 (en) 2009-02-26
KR20070101241A (ko) 2007-10-16
MX2007005435A (es) 2007-07-24
EP1810027A4 (en) 2008-05-28
ZA200703666B (en) 2008-10-29
AU2005304819A1 (en) 2006-05-18
JP2008519283A (ja) 2008-06-05
WO2006052857A2 (en) 2006-05-18
EP1810027A2 (en) 2007-07-25
WO2006052857A3 (en) 2006-10-19
NO20072615L (no) 2007-08-06
CA2586922A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
PL2021796T3 (pl) Diagnozowanie choroby sercowo-naczyniowej
GB2477868A (en) Methods and systems for incorporating multiple environmental and genetic risk factors
WO2008030273A3 (en) Compositions and methods for diagnosis and treatment of type 2 diabetes
WO2008097277A3 (en) Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181
WO2004096985A3 (en) Methods for assessing biologic diversity
EP1745287A4 (en) DIAGNOSIS AND MONITORING OF INFLAMMATORY DISEASES BY MEASURING THE ADDITIONAL COMPONENTS OF LEUKOCYTES
NO20080010L (no) GPCR-agonister
WO2008004159A3 (en) Wearable blood pressure monitoring system
BRPI0507442B8 (pt) método in vitro de diagnóstico de um indivíduo humano gestante como apresentando ou com uma propensão a desenvolver pré-eclâmpsia ou eclâmpsia
HK1136943A1 (en) Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
WO2012018535A3 (en) Wellness panel
DK1800134T3 (da) Fremgangsmåde til diagnosticering og behandling af Chron's sygdom
WO2009055001A3 (en) Methods of treating aging and methods of screening candidate agents therefor
DE602005014778D1 (de) Timp-2 als ziel/marker des versagens von beta-zellen
TW200833688A (en) Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
WO2009063226A3 (en) Methods relating to breathing disorders
ATE527937T1 (de) Patientenüberwachungssystem
WO2007079301A3 (en) Method of diagnosing a body weight condition or predisposition in an animal
BRPI0515727A (pt) biomarcador para insuficiência cardìaca
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
WO2006129867A3 (en) ENHANCED EXPRESSION OF LACTOFERRIN mRNA BY LACRITIN
FR2930036B1 (fr) Procede de diagnostic d'une hypertension arterielle pulmonaire.
DK2196545T3 (da) Fremgangsmåder til forudsigelse af reaktionen hos patienter med dissemineret sclerose på interferonbehandling samt diagnosticering af dissemineret sclerose
WO2008009857A3 (fr) Modulateurs de la udp-glucose céramide glucosyltransférase dans le traitement de l'acné ou de l'hyperkératinisation
WO2008009859A3 (fr) Modulateurs de scarb-1 dans le traitement de l'acné ou de l'hyperséborrhée

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 6A ANUIDADE.